ArticleProteomics2020
A User-Friendly Visualization Tool for Multi-Omics Data.
Article in Proteomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Omics Sciences in Regular Physical Activity.International journal of molecular sciences · 2025Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Clinical Proteomic Tumor Analysis Consortium (CPTAC) initiative has generated large multi-omic datasets for various cancers. Each dataset consists of common and differential data types, including genomics, epigenomics, transcriptomics, proteomics, and post-translational modifications data. They together make up a rich resource for researchers and clinicians interested in understanding cancer biology to draw from. Nevertheless, the complexity of these multi-omic datasets and a lack of an easily accessible analytical and visualization tool for exploring them continue to be a hurdle for those who are not trained in bioinformatics. In this issue, Calinawan et al. describe a user-friendly, web-based visualization platform named ProTrack for exploring the CPTAC clear cell renal cell carcinoma (ccRCC) dataset. Compared to other available visualization tools, ProTrack offers an easy yet powerful customization interface, solely dedicated to the CPTAC ccRCC dataset. Their tool enables ready inspection of potential associations between different data types within a single gene or across multiple genes without any need to code. Specific mutation types or phosphosites can also be easily looked up for any gene of interest. Calinawan et al. aim to extend their work into other CPTAC datasets, which will greatly contribute to the CPTAC as well as cancer biology community in general.
Indexed as
Identifiers
32744797What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.